EICHORPublic-registry site landscape for NCT06537999, “A Clinical Study to Evaluate DNTH103 in Adults With Multifocal Motor Neuropathy”, a Multifocal Motor Neuropathy study sponsored by Dianthus Therapeutics. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT06537999 (registry record) |
| Study title | A Clinical Study to Evaluate DNTH103 in Adults With Multifocal Motor Neuropathy |
| Official title | A Phase 2, Randomized, Double-Blinded, Placebo-Controlled, Study to Evaluate Safety, Tolerability, Pharmacometrics, and Efficacy of DNTH103 in Adults With Multifocal Motor Neuropathy (MOMENTUM) |
| Sponsor | Dianthus Therapeutics |
| Condition(s) | Multifocal Motor Neuropathy |
| Phase | PHASE2 |
| Listed sites | 41 |
| Site countries | United States, Canada, China, Denmark, France, Italy, Malaysia, Netherlands, North Macedonia, Poland, Serbia, South Korea |
Patient-friendly overview of this study: eichor.com/study/NCT06537999.
Eichor generates a preliminary site-risk snapshot for NCT06537999 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
